Heidi Anderson

Heidi Anderson serves as a key procurement professional within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical solutions for infectious, immunologic, and allergic diseases. She manages complex acquisitions focused on advanced software systems that enable data integration, bioinformatics, and laboratory information management critical to public health response. Her work directly supports NIAID’s strategic priorities in developing diagnostic tools, genomic analysis platforms, and biosafety infrastructure, ensuring that technical capabilities align with emerging threat landscapes and federal research requirements. She typically handles full lifecycle contract actions under FAR and HHS-specific acquisition regulations, with a focus on research-enabling software and data infrastructure. Anderson’s primary contractor relationships center on Quality Biological, Inc., a leading provider of biological reference materials and laboratory support services, and GENOMIC LABS LTD, a specialized provider of genomic sequencing and bioanalytical solutions. These partnerships reflect a preference for established vendors with proven expertise in high-containment research environments and compliance with biosafety standards. Her contracting patterns emphasize technical reliability, regulatory alignment, and scalability of software platforms to support multi-institutional research consortia and rapid-response capabilities. Anderson’s procurement portfolio reflects a 100% non-set-aside approach, indicating a focus on technical merit and mission-critical capability over socioeconomic preferences. While small business participation is not formally prioritized, her awards consistently favor vendors with demonstrated domain expertise in high-complexity biomedical software environments. Her primary NAICS classification is 513210 (Software Publishers), underscoring her specialization in procuring custom and commercial off-the-shelf software for genomic data analysis, pathogen surveillance systems, and laboratory information management systems. She frequently acquires cloud-enabled platforms, secure data exchange tools, and AI-driven analytical tools that support NIAID’s research infrastructure and emergency response readiness.